# Caffeine intake and late dry age-related macular degeneration: tea’s protective role—insights from NHANES and Mendelian randomization

**Authors:** Hongli Yang, Boshi Liu, Yunxi Zhang, Zhanhe Zhang, Huang Tan, Xiaorong Li

PMC · DOI: 10.1186/s40942-026-00813-6 · 2026-02-16

## TL;DR

Tea consumption may protect against late dry age-related macular degeneration, possibly by modulating immune cells, according to data from NHANES and Mendelian randomization.

## Contribution

This study identifies tea as a protective dietary source of caffeine against dry AMD through causal and immunological analyses.

## Key findings

- Caffeine intake was inversely associated with late AMD in NHANES data.
- MR analysis showed tea consumption was causally linked to reduced dry AMD risk.
- Tea's protective effect may involve downregulation of specific immune cell profiles.

## Abstract

Although caffeine is widely consumed and has demonstrated neuroprotective effects, its role in age-related macular degeneration (AMD) remains unclear, particularly across disease subtypes and dietary sources such as tea and coffee.

We analyzed 2005–2008 NHANES data using weighted logistic regression and restricted cubic splines to assess the dose–response relationship between caffeine intake and the prevalence of early and late AMD. Two-sample Mendelian randomization (MR) using GWAS summary statistics was employed to evaluate causal effects of tea and coffee consumption on AMD subtypes. Furthermore, a two-step MR approach was utilized to identify potential immune-mediated pathways.

NHANES data showed that caffeine intake was inversely associated with late AMD (fully adjusted OR = 0.65, 95% CI: 0.44–0.96). Dose–response modeling revealed an L-shaped nonlinear relationship (P for nonlinear = 0.046), indicating that the protective effect of caffeine plateaued once daily intake exceeded approximately 110–150 mg. MR analysis further supported a causal protective association between tea consumption and dry AMD, including geographic atrophy (OR = 0.44, 95% CI: 0.20–0.97), which may be partially attributable to immunological mechanisms, specifically the downregulation of secretory regulatory T cells (% of CD4 + Tregs) and CD45RA- CD4 + T cell (% of CD4 + T cell). In contrast, coffee consumption showed no significant effect.

Tea, a specific source of caffeine typically corresponding to moderate intake levels, may confer protection against dry AMD, including geographic atrophy, potentially through modulation of immune cell profiles. These findings suggest a potential preventive strategy and warrant further clinical investigation.

The online version contains supplementary material available at 10.1186/s40942-026-00813-6.

## Linked entities

- **Chemicals:** caffeine (PubChem CID 2519)
- **Diseases:** age-related macular degeneration (MONDO:0005150), dry AMD (MONDO:0100114)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}
- **Diseases:** AMD (MESH:D008268), geographic atrophy (MESH:D057092)
- **Chemicals:** Caffeine (MESH:D002110)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13014731/full.md

---
Source: https://tomesphere.com/paper/PMC13014731